Positioning strategies in the value‐added chain of the biopharmaceutical sector: the case of UK SMEs

Călin Gurău (Professor in Marketing at the Centre d'Etudes et de Recherche sur les Organisations et le Management (CEROM), Ecole Supérieure de Commerce Montpellier, Montpellier, France)

Journal of Consumer Marketing

ISSN: 0736-3761

Publication date: 1 December 2004

Abstract

One of the major functions of marketing strategy is the proper positioning of the company in the sectorial value‐added chain, in order to create the best possible competitive advantage. This process is extremely important, especially for small and medium‐sized enterprises (SMEs), since any wrong decision can literally eliminate the company from the market. This paper attempts to analyse and present the strategic positioning process specific to small and medium‐sized biopharmaceutical firms in the UK. After discussing the specific characteristics of the value chain in the biopharmaceuticals sector, the paper presents the research methodology used to collect primary and secondary data. Data analysis leads towards a theoretical model that describes the stages and the factors influencing the strategic positioning of SMEs in the value‐added chain of the biopharmaceuticals sector.

Keywords

Citation

Gurău, C. (2004), "Positioning strategies in the value‐added chain of the biopharmaceutical sector: the case of UK SMEs", Journal of Consumer Marketing, Vol. 21 No. 7, pp. 476-485. https://doi.org/10.1108/07363760410568699

Download as .RIS

Publisher

:

Emerald Group Publishing Limited

Copyright © 2004, Emerald Group Publishing Limited

Please note you might not have access to this content

You may be able to access this content by login via Shibboleth, Open Athens or with your Emerald account.
If you would like to contact us about accessing this content, click the button and fill out the form.
To rent this content from Deepdyve, please click the button.